Open-Label,Singel Center Study of Alefacept in Patients With Atopic Dermatitis

NCT00376129 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Alefacept

Sponsor

Insel Gruppe AG, University Hospital Bern

Collaborators

[object Object]